Stefano Caruso

Inserm — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

40h-index4.7kcitations164works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA modifications and cancer(29), Cholangiocarcinoma and Gallbladder Cancer Studies(28), Cancer-related molecular mechanisms research(26), MicroRNA in disease regulation(19), Hepatocellular Carcinoma Treatment and Prognosis(19)

Publications162 total

Feasibility and Effectiveness of Liver Transplantation following Immunotherapy in Patients with Hepatocellular Carcinoma
Liver Cancer·2025Open Access
Influence of sex and gender-related factors on the knowledge of generic medicines among older patients and caregivers
Internal and Emergency Medicine·2025Open Access
Intratumour ploidy heterogeneity and clonal evolution in hepatocellular carcinoma
Journal of Hepatology·2025· 1 citedOpen Access
Evidence of rainfall-driven disruptions in respiratory epidemics surveillance
2025Open Access
Prevalence of advanced liver fibrosis in the general population of the Paris region according to FIB-4 score and liver risk score
BMC Gastroenterology·2025Open Access
THU-285 Prognostic factors in autoimmune hepatitis: a french multicenter study
Journal of Hepatology·2025
SAT-303 Comprehensive analysis of the intrahepatic immune microenvironment and gene expression profiles in a large cohort of patients with untreated hepatitis B virus infection
Journal of Hepatology·2025
FRI-007 An algorithm based on the liver risk score to identify subjects at-risk for advanced liver disease in the general population
Journal of Hepatology·2025
FRI-481 Feasibility and effectiveness of liver transplantation following immunotherapy in patients with hepatocellular carcinoma
Journal of Hepatology·2025
SAT-327-YI Advanced phenotyping of hepatic involvement in AL Amyloidosis: the D-Amy-LIPHE study
Journal of Hepatology·2025
Characterization of the intrahepatic immune microenvironment in a large cohort of patients with untreated hepatitis B virus infection
Digestive and Liver Disease·2025
SAT-449 Prevalence of advanced liver fibrosis in the general population of the Paris region according to FIB 4 scores and liver risk score (Cerbafib)
Journal of Hepatology·2024
SAT-386-YI Characterization of intrahepatic immune microenvironment in liver biopsies across different phases of untreated HBeAg-negative patients
Journal of Hepatology·2024
TOP-552 Oncogenic beta-catenin is using CD155 as a molecular actor to corrupt immunosurveillance of cold HCC
Journal of Hepatology·2024
WED-178 Enhanced liver phenotyping in unexplained chronic liver disease: the LIPHE algorithm
Journal of Hepatology·2024
DLK1/DIO3 locus upregulation by a β-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis
Molecular Therapy·2024· 10 citedOpen Access
Combined hepatocellular-cholangiocarcinoma compared to hepatocellular carcinoma and intrahepatic cholangiocarcinoma: Different survival, similar recurrence
Surgery·2023· 15 citedOpen Access
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
Nature Communications·2023· 65 citedOpen Access
Omicron induced distinct immune respiratory transcriptomics signatures compared to pre‐existing variants in critically ill COVID‐19 patients
Journal of Medical Virology·2023· 9 citedOpen Access
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
The Lancet Oncology·2023· 90 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Jessica Zucman‐Rossi(32), Julien Caldéraro(20), Valérie Paradis(14), Jean‐Charles Nault(13), Éric Letouzé(12), Gabrielle Couchy(11), Sandrine Imbeaud(11), Daniele Fanale(10), Sandra Rebouissou(9), Théo Z. Hirsch(9), Giuliana Amaddeo(9), Quentin Bayard(9), Viviana Bazan(9), Antonio Russo(9), Alexis Laurent(8), Guillaume Morcrette(7), Jean‐Frédéric Blanc(7), Catherine Guettier(7), Léa Meunier(7), Paulette Bioulac‐Sage(6)